News Briefing channel feed

Seres re­ceives $125M pay­ment from Nestlé; French biotech teas­es ear­ly-stage eye dis­ease da­ta

Last year

Cor­rect­ed: Bench­Sci rais­es $70M Se­ries D for drug dis­cov­ery soft­ware; Zen­tal­is touts PhIb ovar­i­an can­cer da­ta

Last year

Boehringer In­gel­heim ex­tends 2020 col­lab with Ox­ford Bio­Ther­a­peu­tics; Eu­ro­pean biotechs claim pos­i­tive PhI I/O da­ta

Last year

Ipsen giv­en an ad­comm date for palo­varotene; Am­brx Bio­phar­ma looks to se­cure $75M in lat­est se­cu­ri­ties of­fer­ing

Last year

Pri­or­i­ty re­view for Take­da’s ul­tra-rare blood clot ERT; FDA to give an­oth­er look at Arde­lyx’s CKD drug

Last year
FDA+

BioX­cel touts healthy vol­un­teer da­ta for neu­ro ther­a­py; Io­n­is, Chi­nook part­ner on rare kid­ney dis­ease

Last year

Verve names sec­ond PC­SK9 can­di­date; Ex­sci­en­tia picks an­oth­er AI-cre­at­ed mol­e­cule for clin­ic

Last year

Fu­sion and Cyteir re­fo­cus pipelines; Nona Bio­sciences col­lab­o­rat­ing with Phar­maEssen­tia

Last year

Deer­field launch­es ra­dio­ther­a­py com­pa­ny; UCLA gene edit­ing spin­out se­cures funds

Last year

Leg­end Biotech looks to raise ad­di­tion­al $350M in stock sale; Acasti com­mits to lay­offs

3 years ago

Ak­ili out­lines adult AD­HD da­ta for pre­scrip­tion video game; Medtech start­up to go pub­lic via SPAC

3 years ago

New Jer­sey biotech plans for tiny IPO; Vir gets $10M Gates Foun­da­tion grant for HIV vac­cine

3 years ago

Bris­tol My­ers gets pri­or­i­ty re­view for first-line Re­blozyl; Two star­tups clinch new cash

3 years ago

Janssen gets pri­or­i­ty re­view for prostate can­cer com­bo; Im­muno­Gen re­ports Q1 Ela­here sales

3 years ago

4DMT un­veils dose ex­plo­ration da­ta in wet AMD; Ex­i­cure in­stalls new C-suite ex­ec

3 years ago

Astel­las and Twist team up in an­ti­bod­ies; FDA asks DBV for an ad­di­tion­al safe­ty study in peanut al­ler­gy patch

3 years ago

Gami­da Cell looks to get $22M+ on its pub­lic of­fer­ing launch; Es­pe­ri­on signs co-pro­mo­tion pact with Cur­rax

3 years ago

Ot­su­ka sub­sidiary gets date with FDA for Lon­surf com­bo; Vax­cyte sells stock to bankroll PhI­II vac­cine tri­al

3 years ago

Smart Im­mune picks up $5M from Gates Foun­da­tion; Ox­ford Nanopore teams up with French di­ag­nos­tics play­er

3 years ago

FDA asks Soli­genix for new study af­ter RTF; Navidea sells imag­ing agent for Alzheimer's

3 years ago

Treg play­er Gen­tiBio turns to lay­offs; Cen­tu­ry Ther­a­peu­tics CEO de­parts

3 years ago

Bavar­i­an Nordic gath­ers pa­tients for PhI­II RSV tri­al; Adap­ti­m­mune hand­ed $37M+ as GSK part­ner­ship ends

3 years ago

Hori­zon touts PhIV win for Te­pez­za; FDA sets ad­comm dates for Sarep­ta, Pfiz­er, Ei­sai apps

3 years ago

ADC biotech brings to­tal Se­ries A raise to $89M+; Take­da hands $40M mile­stone to Ar­row­head

3 years ago
First page Previous page 16171819202122 Next page Last page
A service from the Financial Times